1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type1.2.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Anti-allergy 1.2.3 Anti-VEGF Agents 1.2.4 Anti-inflammatory 1.2.5 Anti-glaucoma 1.2.6 Others 1.3 Market by Application1.3.1 Global Ophthalmic Therapeutics/Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Dry Eye 1.3.3 Allergies 1.3.4 Glaucoma 1.3.5 Infection 1.3.6 Retinal Disorders 1.3.7 Uveitis 1.3.8 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Ophthalmic Therapeutics/Drug Market Perspective (2016-2027) 2.2 Ophthalmic Therapeutics/Drug Growth Trends by Regions2.2.1 Ophthalmic Therapeutics/Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Ophthalmic Therapeutics/Drug Historic Market Share by Regions (2016-2021) 2.2.3 Ophthalmic Therapeutics/Drug Forecasted Market Size by Regions (2022-2027) 2.3 Ophthalmic Therapeutics/Drug Industry Dynamic2.3.1 Ophthalmic Therapeutics/Drug Market Trends 2.3.2 Ophthalmic Therapeutics/Drug Market Drivers 2.3.3 Ophthalmic Therapeutics/Drug Market Challenges 2.3.4 Ophthalmic Therapeutics/Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue3.1.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue (2016-2021) 3.1.2 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Players (2016-2021) 3.2 Global Ophthalmic Therapeutics/Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Ophthalmic Therapeutics/Drug Revenue 3.4 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio3.4.1 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutics/Drug Revenue in 2020 3.5 Ophthalmic Therapeutics/Drug Key Players Head office and Area Served 3.6 Key Players Ophthalmic Therapeutics/Drug Product Solution and Service 3.7 Date of Enter into Ophthalmic Therapeutics/Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Ophthalmic Therapeutics/Drug Breakdown Data by Type 4.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Type (2016-2021) 4.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Type (2022-2027) 5 Ophthalmic Therapeutics/Drug Breakdown Data by Application 5.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Application (2016-2021) 5.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Ophthalmic Therapeutics/Drug Market Size (2016-2027) 6.2 North America Ophthalmic Therapeutics/Drug Market Size by Type6.2.1 North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 6.2.2 North America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 6.2.3 North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 6.3 North America Ophthalmic Therapeutics/Drug Market Size by Application6.3.1 North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 6.3.2 North America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 6.3.3 North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 6.4 North America Ophthalmic Therapeutics/Drug Market Size by Country6.4.1 North America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) 6.4.2 North America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Ophthalmic Therapeutics/Drug Market Size (2016-2027) 7.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type7.2.1 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 7.2.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 7.2.3 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 7.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application7.3.1 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 7.3.2 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 7.3.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 7.4 Europe Ophthalmic Therapeutics/Drug Market Size by Country7.4.1 Europe Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) 7.4.2 Europe Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size (2016-2027) 8.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type8.2.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application8.3.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region8.4.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Ophthalmic Therapeutics/Drug Market Size (2016-2027) 9.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Type9.2.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 9.2.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 9.2.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 9.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Application9.3.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 9.3.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 9.3.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 9.4 Latin America Ophthalmic Therapeutics/Drug Market Size by Country9.4.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) 9.4.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size (2016-2027) 10.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type10.2.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application10.3.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country10.4.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Alcon11.1.1 Alcon Company Details 11.1.2 Alcon Business Overview 11.1.3 Alcon Ophthalmic Therapeutics/Drug Introduction 11.1.4 Alcon Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.1.5 Alcon Recent Development 11.2 Johnson and Johnson Vision Care, Inc.11.2.1 Johnson and Johnson Vision Care, Inc. Company Details 11.2.2 Johnson and Johnson Vision Care, Inc. Business Overview 11.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Introduction 11.2.4 Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.2.5 Johnson and Johnson Vision Care, Inc. Recent Development 11.3 Bausch & Lomb Incorporated11.3.1 Bausch & Lomb Incorporated Company Details 11.3.2 Bausch & Lomb Incorporated Business Overview 11.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Introduction 11.3.4 Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.3.5 Bausch & Lomb Incorporated Recent Development 11.4 Novartis AG11.4.1 Novartis AG Company Details 11.4.2 Novartis AG Business Overview 11.4.3 Novartis AG Ophthalmic Therapeutics/Drug Introduction 11.4.4 Novartis AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.4.5 Novartis AG Recent Development 11.5 Merck Sharp & Dohme Corp.11.5.1 Merck Sharp & Dohme Corp. Company Details 11.5.2 Merck Sharp & Dohme Corp. Business Overview 11.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Introduction 11.5.4 Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.5.5 Merck Sharp & Dohme Corp. Recent Development 11.6 Regeneron Pharmaceuticals Inc.11.6.1 Regeneron Pharmaceuticals Inc. Company Details 11.6.2 Regeneron Pharmaceuticals Inc. Business Overview 11.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Introduction 11.6.4 Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.6.5 Regeneron Pharmaceuticals Inc. Recent Development 11.7 Allergan11.7.1 Allergan Company Details 11.7.2 Allergan Business Overview 11.7.3 Allergan Ophthalmic Therapeutics/Drug Introduction 11.7.4 Allergan Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.7.5 Allergan Recent Development 11.8 Pfizer Inc.11.8.1 Pfizer Inc. Company Details 11.8.2 Pfizer Inc. Business Overview 11.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Introduction 11.8.4 Pfizer Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.8.5 Pfizer Inc. Recent Development 11.9 Valeant11.9.1 Valeant Company Details 11.9.2 Valeant Business Overview 11.9.3 Valeant Ophthalmic Therapeutics/Drug Introduction 11.9.4 Valeant Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.9.5 Valeant Recent Development 11.10 Bayer AG11.10.1 Bayer AG Company Details 11.10.2 Bayer AG Business Overview 11.10.3 Bayer AG Ophthalmic Therapeutics/Drug Introduction 11.10.4 Bayer AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.10.5 Bayer AG Recent Development 11.11 Santen Pharmaceuticals Co. Ltd11.11.1 Santen Pharmaceuticals Co. Ltd Company Details 11.11.2 Santen Pharmaceuticals Co. Ltd Business Overview 11.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Introduction 11.11.4 Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.11.5 Santen Pharmaceuticals Co. Ltd Recent Development 11.12 Genentech, Inc.11.12.1 Genentech, Inc. Company Details 11.12.2 Genentech, Inc. Business Overview 11.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Introduction 11.12.4 Genentech, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021) 11.12.5 Genentech, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer
Ophthalmic Therapeutics/Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Therapeutics/Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Segment by Application
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Novartis AG
Merck Sharp & Dohme Corp.
Summary: Get latest Market Research Reports on Ophthalmic Therapeutics/Drug . Industry analysis & Market Report on Ophthalmic Therapeutics/Drug is a syndicated market report, published as Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Ophthalmic Therapeutics/Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 19 January, 2021